Pfizer

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pfizer and other ETFs, options, and stocks.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
79,000
Employees79,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
79,000
Employees79,000

PFE Key Statistics

Market cap
245.99B
Market cap245.99B
Price-Earnings ratio
8.57
Price-Earnings ratio8.57
Dividend yield
3.63
Dividend yield3.63
Average volume
17.98M
Average volume17.98M
High today
$44.61
High today$44.61
Low today
$43.73
Low today$43.73
Open price
$44.36
Open price$44.36
Volume
22.96M
Volume22.96M
52 Week high
$61.71
52 Week high$61.71
52 Week low
$40.94
52 Week low$40.94

PFE News

Simply Wall St 2d
Pfizer Seems To Use Debt Rather Sparingly - Simply Wall St

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a...

Pfizer Seems To Use Debt Rather Sparingly - Simply Wall St
Simply Wall St 4d
Pfizer Inc.'s Earnings Are Not Doing Enough For Some Investors

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 14x, you may consider Pfizer Inc. (NYSE:PFE) as an attrac...

Pfizer Inc.'s Earnings Are Not Doing Enough For Some Investors
Investor's Business Daily 6d
Pfizer's Covid Sales Are Expected To Decline, Again — Is PFE Stock Now A Sell?

Pfizer stock is heading south in September after the company announced its plan to buy Global Blood Therapeutics (GBT) and won Food and Drug Administration auth...

Pfizer's Covid Sales Are Expected To Decline, Again — Is PFE Stock Now A Sell?

Analyst ratings

57%

of 23 ratings
Buy
43.5%
Hold
56.5%
Sell
0%

PFE Earnings

$0.00
$0.68
$1.36
$2.04
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Available Nov 1, Pre-Market
ActualAvailable Nov 1, Pre-Market

More PFE News

MarketWatch 6d
Pfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11 - MarketWatch

Pfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for their omicron-targeting bivalent vaccine for use i...

Pfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11 - MarketWatch
Benzinga 7d
Pfizer/BioNTech Seek FDA Emergency Nod For Updated COVID-19 Shot For Kids Under 11 Years

Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have completed an FDA submission seeking Emergency Use Authorization (EUA) for a 10-µg booster dose for Om...

Pfizer/BioNTech Seek FDA Emergency Nod For Updated COVID-19 Shot For Kids Under 11 Years
Benzinga 7d
Pfizer CEO Contracts COVID-19 Infection For Second Time

by Pfizer Inc's PFE CEO Albert Bourla said he had tested positive for COVID-19. CEO Albert Bourla said he had tested positive for COVID-19. "I'm feeling well...

Pfizer CEO Contracts COVID-19 Infection For Second Time
MarketWatch 7d
Pfizer, BioNTech Ask FDA to Approve Booster for Children - MarketWatch

By Dean Seal Pfizer Inc. and partner BioNTech SE have asked the U.S. Food and Drug Administration to approve the use of its Omicron-specific Covid-19 vaccine b...

Pfizer, BioNTech Ask FDA to Approve Booster for Children - MarketWatch
Reuters 7d
Pfizer/BioNTech seek FDA nod for new COVID boosters for children - Reuters

A child receives a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) pediatric vaccine during a mass vaccination program for children ages 6 to 7 in Ci...

Pfizer/BioNTech seek FDA nod for new COVID boosters for children - Reuters
MarketWatch 7d
Pfizer and BioNTech seek FDA EUA for omicron-targeting booster for use in children aged 5 to 11

Pfizer Inc. PFE, -1.10% and German partner BioNTech SE BNTX, -1.27% said Monday they have submitted an application to the U.S. Food and Drug Administration seek...

Pfizer and BioNTech seek FDA EUA for omicron-targeting booster for use in children aged 5 to 11
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.